Actoxumab (Anti-Cdiff Toxin A)
Actoxumab ( (Anti-Cdiff Toxin A) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2546 |
Sku # | A2546-1mg*25 |
Pricing | 1mg*25, $5070.00 |